Literature DB >> 16441300

A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep.

J E Beever1, M A Smit, S N Meyers, T S Hadfield, C Bottema, J Albretsen, N E Cockett.   

Abstract

Ovine hereditary chondrodysplasia, or spider lamb syndrome (SLS), is a genetic disorder that is characterized by severe skeletal abnormalities and has resulted in substantial economic losses for sheep producers. Here we demonstrate that a non-synonymous T>A transversion in the highly conserved tyrosine kinase II domain of a positional candidate gene, fibroblast growth factor receptor 3 (FGFR3), is responsible for SLS. We also demonstrate that the mutant FGFR3 allele has an additive effect on long-bone length, calling into question the long-standing belief that SLS is inherited as a strict monogenic, Mendelian recessive trait. Instead, we suggest that SLS manifestation is determined primarily by the presence of the mutant FGFR3 allele, but it is also influenced by an animal's genetic background. In contrast to FGFR3 mutations causing dwarfism in humans, this single-base change is the only known natural mutation of FGFR3 that results in a skeletal overgrowth phenotype in any species.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441300     DOI: 10.1111/j.1365-2052.2005.01398.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  22 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

2.  FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

Authors:  Kannan Karuppaiah; Kai Yu; Joohyun Lim; Jianquan Chen; Craig Smith; Fanxin Long; David M Ornitz
Journal:  Development       Date:  2016-04-06       Impact factor: 6.868

Review 3.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

4.  Selective sweep mapping of genes with large phenotypic effects.

Authors:  John P Pollinger; Carlos D Bustamante; Adi Fledel-Alon; Sheila Schmutz; Melissa M Gray; Robert K Wayne
Journal:  Genome Res       Date:  2005-12       Impact factor: 9.043

5.  A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.

Authors:  Reha M Toydemir; Anna E Brassington; Pinar Bayrak-Toydemir; Patrycja A Krakowiak; Lynn B Jorde; Frank G Whitby; Nicola Longo; David H Viskochil; John C Carey; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2006-09-26       Impact factor: 11.025

6.  Whole-genome sequencing reveals a potential causal mutation for dwarfism in the Miniature Shetland pony.

Authors:  Julia Metzger; Alana Christina Gast; Rahel Schrimpf; Janina Rau; Deborah Eikelberg; Andreas Beineke; Maren Hellige; Ottmar Distl
Journal:  Mamm Genome       Date:  2016-12-09       Impact factor: 2.957

Review 7.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

Review 8.  Genetic architecture of body size in mammals.

Authors:  Kathryn E Kemper; Peter M Visscher; Michael E Goddard
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

9.  Microphthalmia in Texel sheep is associated with a missense mutation in the paired-like homeodomain 3 (PITX3) gene.

Authors:  Doreen Becker; Jens Tetens; Adrian Brunner; Daniela Bürstel; Martin Ganter; James Kijas; Cord Drögemüller
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

10.  Balancing selection of a frame-shift mutation in the MRC2 gene accounts for the outbreak of the Crooked Tail Syndrome in Belgian Blue Cattle.

Authors:  Corinne Fasquelle; Arnaud Sartelet; Wanbo Li; Marc Dive; Nico Tamma; Charles Michaux; Tom Druet; Ivo J Huijbers; Clare M Isacke; Wouter Coppieters; Michel Georges; Carole Charlier
Journal:  PLoS Genet       Date:  2009-09-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.